Patient satisfaction and barriers to initiating real‐time continuous glucose monitoring in early pregnancy in women with diabetes
- 26 August 2011
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 29 (2) , 272-277
Abstract
Diabet. Med. 29, 272–277 (2012) Aim To evaluate self‐reported satisfaction and barriers to initiating real‐time continuous glucose monitoring in early pregnancy among women with pregestational diabetes.Methods Fifty‐four women with Type 1 diabetes and 14 women with Type 2 diabetes were offered continuous glucose monitoring for 6 days at median 9 (range 6–14) gestational weeks and were asked to answer a semi‐structured questionnaire on patient satisfaction.Results Median HbA1c was 49 (range 34–86) mmol/mol) [6.6 (5.3–10.0) %] and duration of diabetes was 12 (0.5–37) years. Continuous glucose monitoring was used for 6 (0.5–7) days, with 43 (65%) women using continuous glucose monitoring for at least 5 days. The women experienced 2.7 (0–12) alarms per 24 h, of which approximately one third was technical alarms and one third disturbed their sleep. Sixteen women (24%) reported discomfort with continuous glucose monitoring during daytime and twelve (18%) during sleep. Many women reported improved diabetes understanding (52%) and would recommend continuous glucose monitoring to others (83%). Twenty‐four patients (36%) had continuous glucose monitoring removed earlier than planned ( before the intended 6 days of initial monitoring). Ten women (15%) did not wish to use continuous glucose monitoring again in pregnancy. Main causes behind early removal of continuous glucose monitoring were self‐reported skin irritation, technical problems and continuous glucose monitoring inaccuracy. No differences were found in continuous glucose monitoring use, inconvenience or compliance with respect to diabetes type.Conclusions The majority of pregnant women with diabetes found real‐time continuous glucose monitoring useful and the intervention was equally tolerated regardless of diabetes type. Nevertheless, continuous glucose monitoring was frequently removed earlier than planned, primarily because of skin irritation, technical problems and inaccuracy.Keywords
This publication has 29 references indexed in Scilit:
- Closed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 DiabetesDiabetes Care, 2011
- Effectiveness of Continuous Glucose Monitoring in a Clinical Care EnvironmentDiabetes Care, 2009
- Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 DiabetesDiabetes Care, 2009
- Sustained Benefit of Continuous Glucose Monitoring on A1C, Glucose Profiles, and Hypoglycemia in Adults With Type 1 DiabetesDiabetes Care, 2009
- Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin‐treated diabetes (MITRE Study)Diabetic Medicine, 2009
- The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 DiabetesDiabetes Care, 2009
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trialBMJ, 2008
- Hypoglycemia in Pregnant Women With Type 1 DiabetesDiabetes Care, 2008
- Continuous Glucose Monitoring System With an AlarmDiabetes Care, 2006